Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GA2 malaria sporozoite immunization with adjuvants proof-of-principle study
NL-OMON53441Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Feb 2023
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of bcg vaccine, 17D yellow fever vaccine and imiquimod in malaria, sponsored by Leiden University Medical Center. Started Feb 2023; status: recruiting.
02
Drugs
bcg vaccine17D yellow fever vaccineimiquimod
03
Conditions
malaria
Beyond the preview
Go deeper on NL-OMON53441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON53441.